| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |